NCT06882811View on ClinicalTrials.gov

Human Umbilical Cord Mesenchymal Stem Cells Treatment in Sepsis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 22, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Sepsis
Interventions
BIOLOGICAL

CD83-positive MSC

90 patients are infused with 1×10⁸ stem cells per session and receive regulatory treatment

BIOLOGICAL

regulatory MSC

45 patients are infused with 1×10⁸ stem cells per session and receive regulatory treatment

OTHER

control solution

45 patients are infused with equal volume of control solution and receive regulatory treatment

Trial Locations (1)

400010

RECRUITING

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, Chongqing

All Listed Sponsors
lead

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

OTHER